InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Jenusaitis Matthew, 董事. Director active across 2 companies, notably Hancock Jaffe Laboratories, Inc.. In total, 4 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €32k. Activity tracked since 25 August 2021. The latest transaction was filed on 19 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Jenusaitis Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
9,620 股@ US$2.53100.0% 占其流量Common StockSEC:0001493152-24-051172:0
标准退出：2025年3月19日 (T+90)
1,041 股Common StockSEC:0001493152-22-026070:0
1,042 股Common StockSEC:0001493152-21-022863:0
1,300 股@ US$7.70100.0% 占其流量Common Stock, $$0.00001 par valueSEC:0001493152-21-021444:0
标准退出：2021年11月23日 (T+90)
4 条申报中的 4 条
About Jenusaitis Matthew
Jenusaitis Matthew is a Board Member at Hancock Jaffe Laboratories, Inc. He actively participates in strategic decisions and oversight of the company's operations. His experience in the medical sector is an asset for Hancock Jaffe.
